Ricky McCullough, MD, MScTranslational Medicine Clinic & Research Center, Storrs, CT;rovidence Veterans Administration Medical Center, Department of Medicine, Emergency Division, Brown University School of Medicine, Providence, RI
Evidence-Based Statistics on Complete Prevention and Rapid Sustained Elimination of Chemoradiation Mucositis by High-Potency Polymerized Cross-Linked Sucralfate
February 15, 2018 | February 2018 Vol 9, No 2
This report evaluates the quality of that evidence and provides a plain language review of the statistics regarding the efficacy of High-Potency Polymerized Cross-linked Sucralfate as well as the inherent limitation of some guideline-supported therapies.
Evidence-Based Statistics on Complete Prevention and Rapid Sustained Elimination of Chemoradiation Mucositis by ProThelial
November 14, 2017 | November 2017 Vol 8, No 11
Of the 1.6 million individuals annually diagnosed with cancer, 522,166 received chemoradation, with 234,975 developing toxic mucositis and 20% dying within 5 years due largely to mucositis-mediated unplanned treatment breaks.
Last modified: June 5, 2018